A leading driver and strong advocate for European Businesses in Korea
ECCK Hosts Joint Round Table with AMCHAM on Post COVID-19 In-vitro Diagnostics Technology Trends
On May 18, ECCK Healthcare Committee, together with AMCHAM Medical Device Committee, successfully hosted a joint Round Table under the topic: Post COVID-19 In-vitro Diagnostics Technology Trends.
During the event, multiple sessions were provided to discuss topics such as Technology Trends of In-vitro Diagnostics and Policy of the New Technology. Additionally, various presentations from distinguished professionals and industry experts, including Ms. Sang-Mi Yuk (Director, Medical Technology Listing Division, Health Insurance Review & Assessment Service), Mr. Sung-Eun, Hwang (Director, Department of Medical Devices & Cosmetics Industry, Korea Health Industry Development Institute) and Ms. Chae-Min Shin (Executive Director, Division of New Health Technology Assessment, National Evidence-based Healthcare Collaborating Agency), were provided.
Specialists from private sectors also shared their valuable insights: Mr. DaeWhan Kim (Biomerieux), Mr. Robert McBride & Mr. Nordin Charafi (Illumina), Ms. NaYoung Kwon & Ms. SungMin Kim (Siemens Healthineers) and Mr. Sunghoon Kwon (QuantaMatrix).
We would like to express our appreciation to all the speakers and attendees, as well as our co-host AMCHAM for their interest and support in successfully carrying out the AMCHAM – ECCK Joint Round Table – “Post COVID-19 In-vitro Diagnostics Technology Trends”.
ECCK Hosts Joint Round Table with AMCHAM on Post COVID-19 In-vitro Diagnostics Technology Trends
On May 18, ECCK Healthcare Committee, together with AMCHAM Medical Device Committee, successfully hosted a joint Round Table under the topic: Post COVID-19 In-vitro Diagnostics Technology Trends.
During the event, multiple sessions were provided to discuss topics such as Technology Trends of In-vitro Diagnostics and Policy of the New Technology. Additionally, various presentations from distinguished professionals and industry experts, including Ms. Sang-Mi Yuk (Director, Medical Technology Listing Division, Health Insurance Review & Assessment Service), Mr. Sung-Eun, Hwang (Director, Department of Medical Devices & Cosmetics Industry, Korea Health Industry Development Institute) and Ms. Chae-Min Shin (Executive Director, Division of New Health Technology Assessment, National Evidence-based Healthcare Collaborating Agency), were provided.
Specialists from private sectors also shared their valuable insights: Mr. DaeWhan Kim (Biomerieux), Mr. Robert McBride & Mr. Nordin Charafi (Illumina), Ms. NaYoung Kwon & Ms. SungMin Kim (Siemens Healthineers) and Mr. Sunghoon Kwon (QuantaMatrix).
We would like to express our appreciation to all the speakers and attendees, as well as our co-host AMCHAM for their interest and support in successfully carrying out the AMCHAM – ECCK Joint Round Table – “Post COVID-19 In-vitro Diagnostics Technology Trends”.